The Company

Olerup SSP AB is leading in the development of kits for genomic HLA typing, a required step prior to a transplantation to match the donor and recipient. The better the match the lower the risk of complications following transplantation. HLA typing is a standard procedure prior to bone marrow transplantations (hematopoetic stem cell transplantations) and is also used in conjunction with organ transplantations (kidney, lung, heart, etc.)

Olerup SSP AB was established in 1992 by Associate Professor Olle Olerup. In 1998 the company signed a distribution agreement with GenoVision Vertriebs GmbH and GenoVision Inc. In 2003 GenoVision was acquired by Qiagen GmbH and in 2009 Olerup International acquired these rights from Qiagen.

Olerup SSP AB is committed to the continuous development of the PCR-SSP technique to meet the needs of the future. Most importantly, this involves remaining leaders in supplying our customers with the most up-to-date product line. In addition, Olerup SSP AB will work towards increased automation and thus facilitate for our customers worldwide. Our goal is to contribute to safe and successful organ and haematopoietic stem cell transplantations.